Companies in #Anticoagulation
Found 1 company operating in this sector.
Late-stage biopharmaceutical company (NASDAQ: CVKD) developing tecarfarin, a novel oral reversible anticoagulant for patients with implanted cardiac devices, and CAD-1005, a 12-LOX inhibitor for heparin-induced thrombocytopenia.